- Acquisition provides GRCK with an entry into the CBD market
- Eqova is fully-focused on providing hemp oil health products to partners in the medical practitioner market and plans to dominate that niche
- The CBD market is seen growing 700% to $2.1 billion by 2020, according to The Hemp Business Journal
Grey Cloak Tech, Inc.’s (OTC: GRCK) signing of a binding letter of intent to purchase CBD company Eqova Life Sciences is expected to enable it to enter the medical practitioner market (http://dtn.fm/0itCb). Eqova is a company that’s focused exclusively on offering a full spectrum line of clinical-grade hemp oil products via partnerships with licensed practitioners to use with their patients. The transaction is scheduled to close by October 10, 2017, according to EmergingGrowth.com (http://dtn.fm/Wpp1u).
GRCK is a Las Vegas, Nevada-based company that develops advanced software that is designed to overcome the most costly digital threats. It offers unique systems which are aimed at eliminating online fraud. Its proprietary digital advertising fraud detection software is FraudLytic™, which is a cloud-based platform that monitors internet traffic in real time. Fred Covely, GRCK’s CEO, said on Big Biz Radio that GRCK is focused on detecting digital ad fraud, including the number of ad ‘clicks’ claimed by online advertisers (http://dtn.fm/1ySW0).
Eqova is a Denver, Colorado-based firm that focuses entirely on providing CBD to the medical practitioner market, which GRCK believes is underserved. In addition to its own branded product line of hemp oil health products, it also offers private labels to qualified partners.
The CBD market is seen growing by 700% to $2.1 billion by 2020, according to The Hemp Business Journal (http://dtn.fm/1TTub).
For more information, visit the company’s website at www.GreyCloakTech.com
